Surrozen (SRZN) Profit After Tax (2020 - 2026)
Surrozen (SRZN) recorded quarterly Profit After Tax of -$127.5 million in Q1 2026, up 30.37% quarter-over-quarter from -$183.1 million in Q4 2025, and down 372.22% on a YoY basis from $46.8 million in Q1 2025.
Surrozen (SRZN) Profit After Tax (2020 - 2026) Analysis & Trends
Surrozen's Profit After Tax history runs 7 years deep, the most recent figure standing at -$127.5 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 372.22% year-over-year to -$127.5 million; the TTM figure through Mar 2026 stood at -$342.5 million (down 318.99% YoY), while the FY2025 annual figure was -$242.0 million, down 280.72% from the prior year.
- Profit After Tax was -$127.5 million for Q1 2026 at Surrozen, up from -$183.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $39.7 million in Q2 2025 to a low of -$183.1 million in Q4 2025.
- Historically, Profit After Tax has averaged -$30.1 million across 5 years, with a median of -$13.4 million in 2022.
- Biggest YoY gain for Profit After Tax was 257.34% in 2025; the steepest drop was 4893.03% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$775000.0 in 2022, then tumbled by 1044.65% to -$8.9 million in 2023, then tumbled by 216.07% to -$28.0 million in 2024, then plunged by 553.02% to -$183.1 million in 2025, then jumped by 30.37% to -$127.5 million in 2026.
- The last three Profit After Tax figures came in at -$127.5 million (Q1 2026), -$183.1 million (Q4 2025), and -$71.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | -127.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.50 Mn |
| Dec 31, 2025 | -183.10 Mn |
| Sep 30, 2025 | -71.60 Mn |
| Jun 30, 2025 | 39.75 Mn |
| Mar 31, 2025 | -27.00 Mn |
| Dec 31, 2024 | -28.04 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -25.26 Mn |
| Mar 31, 2024 | -8.83 Mn |
| Dec 31, 2023 | -8.87 Mn |
| Sep 30, 2023 | -10.45 Mn |
| Jun 30, 2023 | -9.39 Mn |
| Mar 31, 2023 | -14.30 Mn |
| Dec 31, 2022 | -775,000.00 |
| Sep 30, 2022 | -13.36 Mn |
| Jun 30, 2022 | -13.90 Mn |
| Mar 31, 2022 | -7.90 Mn |
| Dec 31, 2021 | -14.95 Mn |
| Sep 30, 2021 | -14.02 Mn |
| Jun 30, 2021 | -12.65 Mn |